Cited by 115Medication Adherence and ComplianceLipoproteins and Cardiovascular HealthPharmacy and Medical Practices

The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.

Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy

Benner, Joshua S., Tierce, Jonothan C., Ballantyne, Christie M., Prasad, Cheryl, Bullano, Michael F., Willey, Vincent J., Erbey, John, Sugano, David S.·2004·PharmacoEconomics

DOI 10.2165/00019053-200422003-00003

Open this paper in CoChat — free account

Abstract

Introduction and objective The National Cholesterol Education Program recommends regular physician follow-up and lipid testing to promote adherence with lipid-lowering medications. The objective of this study was to determine whether lipid tests and physician visits after treatment initiation are indeed associated with adherence to statin therapy.Subjects and methods A retrospective cohort study was conducted among 19 422 enrolees in a US managed care plan who initiated treatment with a statin between October 1999 and August 2001. Computerised pharmacy, medical and laboratory records were used to study the patterns and predictors of adherence with lipid-lowering therapy for up to 3 years. Adherence was assessed in 3-month intervals with patients considered 'adherent' if > or = 80% of days were covered by lipid-lowering therapy.Results In the first 3 months, 40% of patients had follow-up lipid tests and only 21% had dyslipidaemia visits (14% had both). Those receiving such care were substantially more likely to be adherent in subsequent intervals. Compared with those without follow-up, the relative odds of adherence were 1.42 and 1.27 for patients with one or more lipid test and one or more dyslipidaemia visit, respectively (95% confidence intervals [CI] 1.33, 1.50 and 1.16, 1.39). Patients who received a follow-up visit and lipid test were 45% more likely to be adherent (95% CI 1.34, 1.55). Similar associations were observed when lipid tests and dyslipidaemia visits occurred later in therapy.Conclusion Early and frequent follow-up by physicians--especially lipid testing--was associated with improved adherence to lipid-lowering therapy. A randomised prospective study is needed to determine whether this relationship is causal.

Integrity signals

Registry

Crossref · 10.2165/00019053-200422003-00003

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,638
Prescribing Personalized Nutrition for Cardiovascular Health: Are We Ready?
Juma, S., Imrhan, V., Vijayagopal, P., & Prasad, C. (2014) · Lifestyle Genomics · doi:10.1159/000370213 · Cited by 1,908
Self-citation

Show all 37 references

Sorted by citations

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.003 · Cited by 2,691
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.002 · Cited by 1,751
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C. T., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S. D., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000624 · Cited by 933
Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report
Jacobson, T. A., Ito, M. K., Maki, K. C., Orringer, C. E., Bays, H. E., Jones, P. H., McKenney, J. M., Grundy, S. M., Gill, E. A., Wild, R. A., et al. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.02.003 · Cited by 781
Measurement of Adherence in Pharmacy Administrative Databases: A Proposal for Standard Definitions and Preferred Measures
Hess, L. M., Raebel, M. A., Conner, D. A., & Malone, D. C. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h018 · Cited by 778
A Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases
Peterson, A. M., Nau, D. P., Cramer, J. A., Benner, J., Gwadry-Sridhar, F. H., & Nichol, M. B. (2006) · Value in Health · doi:10.1111/j.1524-4733.2006.00139.x · Cited by 638
Self-citation
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Rao, S. V., O’Donoghue, M. L., Ruel, M., Rab, T., Tamis-Holland, J. E., Alexander, J. H., Baber, U., Baker, H., Cohen, M. G., Cruz-Ruiz, M., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001309 · Cited by 625
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
Rao, S. V., O’Donoghue, M. L., Ruel, M., Rab, T., Tamis-Holland, J. E., Alexander, J. H., Baber, U., Baker, H., Cohen, M. G., Cruz-Ruiz, M., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.11.009 · Cited by 668
The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review
Cramer, J. A., Benedict, Á., Muszbek, N., Keskinaslan, A., & Khan, Z. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01630.x · Cited by 488
Prevalence of statin intolerance: a meta-analysis
Bytyçi, I., Penson, P. E., Mikhailidis, D. P., Wong, N. D., Hernandez, A. V., Sahebkar, A., Thompson, P. D., Mazidi, M., Rysz, J., Pella, D., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac015 · Cited by 481
Predictors of Nonadherence to Statins: A Systematic Review and Meta-Analysis
Mann, D. M., Woodward, M., Muntner, P., Falzon, L., & Kronish, I. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1p150 · Cited by 329
Gender and racial disparities in adherence to statin therapy: A meta-analysis
Lewey, J., Shrank, W. H., Bowry, A. D. K., Kilabuk, E., Brennan, T. A., & Choudhry, N. K. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.02.011 · Cited by 267
2020 Clinical practice guidelines for Acute ST-segment elevation myocardial infarction
Russian Society of Cardiology (2020) · Russian Journal of Cardiology · doi:10.15829/29/1560-4071-2020-4103 · Cited by 271
Disorders of lipid metabolism. Clinical Guidelines 2023
Владиславович, Е. М., Kukharchuk, V. V., Сергиенко, И. В., Alieva, A. S., Antsiferov, M. B., Ansheles, A. A., Arabidze, G. G., Dm, A., Arutyunov, G. P., Ахмеджанов, Н. М., et al. (2023) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2023-5471 · Cited by 270
Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update
Liu, L., Li, Z., Zhou, H., Duan, W., Huo, X., Xu, W., Li, S., Nie, X., Liu, H., Liu, J., et al. (2023) · Stroke and Vascular Neurology · doi:10.1136/svn-2023-002998 · Cited by 227
Proportion and Risk Indicators of Nonadherence to Statin Therapy: A Meta-analysis
Lemstra, M., Blackburn, D. F., Crawley, A., & Fung, R. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.05.007 · Cited by 201
Physician Follow-up and Provider Continuity Are Associated With Long-term Medication Adherence
Brookhart, M. A. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.8.847 · Cited by 198
Adherence to Statin Therapy Among US Adults Between 2007 and 2014
Colantonio, L. D., Rosenson, R. S., Deng, L., Monda, K. L., Dai, Y., Farkouh, M. E., Safford, M. M., Philip, K. J., Mues, K. E., & Muntner, P. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010376 · Cited by 155
Continuation of Statin Treatment and All-Cause Mortality
Shalev, V., Chodick, G., Silber, H., Kokia, E. S., Jan, J., & Heymann, A. D. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.552 · Cited by 153
Predictors of Adherence to Statins for Primary Prevention
Mann, D. M., Allegrante, J. P., Natarajan, S., Halm, E. A., & Charlson, M. E. (2007) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-007-6040-4 · Cited by 149
Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel
Chodick, G., Shalev, V., Gerber, Y., Heymann, A. D., Silber, H., Simah, V., & Kokia, E. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.11.012 · Cited by 145
Racial/Ethnic and Gender Gaps in the Use of and Adherence to Evidence-Based Preventive Therapies Among Elderly Medicare Part D Beneficiaries After Acute Myocardial Infarction
Lauffenburger, J. C., Robinson, J. G., Oramasionwu, C. U., & Fang, G. (2013) · Circulation · doi:10.1161/circulationaha.113.002658 · Cited by 142
Non-adherence to statin therapy: a major challenge for preventive cardiology
Bates, T., Connaughton, V., & Watts, G. F. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903376186 · Cited by 137
Factors Related to Adherence to Statin Therapy
McGinnis, B., Olson, K. L., Magid, D. J., Bayliss, E., Korner, E. J., Brand, D. W., & Steiner, J. F. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k209 · Cited by 121
Impact of statin copayments on adherence and medical care utilization and expenditures.
Gibson, T. B., Mark, T. L., Axelsen, K. J., Baser, O., Rublee, D. A., & McGuigan, K. A. (2006) · PubMed · Cited by 110
Medication nonfulfillment rates and reasons: narrative systematic review
Gadkari, A. S., & McHorney, C. A. (2010) · Current Medical Research and Opinion · doi:10.1185/03007990903550586 · Cited by 103
Persistence with Statins and Onset of Rheumatoid Arthritis: A Population-Based Cohort Study
Chodick, G., Amital, H., Shalem, Y., Kokia, E. S., Heymann, A. D., Porath, A., & Shalev, V. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000336 · Cited by 99
The effects of prescription drug copayments on statin adherence.
Gibson, T. B., Mark, T. L., McGuigan, K. A., Axelsen, K. J., & Wang, S. S. (2006) · PubMed · Cited by 99
How can we improve antidepressant adherence in the management of depression? A targeted review and 10 clinical recommendations
Solmi, M., Miola, A., Croatto, G., Pigato, G., Favaro, A., Fornaro, M., Berk, M., Smith, L., Quevedo, J., Maes, M., et al. (2020) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2020-0935 · Cited by 79
Adherence to preventive statin therapy according to socioeconomic position
Wallach‐Kildemoes, H., Andersen, M. T., Diderichsen, F., & Lange, T. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1488-6 · Cited by 71
A Pharmaceutical Care Program to Improve Adherence to Statin Therapy: A Randomized Controlled Trial
Eussen, S. R. B. M., van der Elst, M. E., Klungel, O. H., Rompelberg, C. J. M., Garssen, J., Oosterveld, M., de Boer, A., de Gier, J. J., & Bouvy, M. L. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1p281 · Cited by 68
Provider understanding of the 2013 ACC/AHA cholesterol guideline
Virani, S. S., Pokharel, Y., Steinberg, L., Chan, W., Akeroyd, J. M., Gowani, S. A., Kalra, A., Polsani, V. R., Miedema, M. D., Jones, P. H., et al. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.11.002 · Cited by 64
Self-citation
Incorporating Tailored Interactive Patient Solutions Using Interactive Voice Response Technology to Improve Statin Adherence: Results of a Randomized Clinical Trial in a Managed Care Setting
Stacy, J. N., Schwartz, S. M., Ershoff, D. H., & Shreve, M. S. (2009) · Population Health Management · doi:10.1089/pop.2008.0046 · Cited by 63
Relationship between Adherence Level to Statins, Clinical Issues and Health-Care Costs in Real-Life Clinical Setting
Dragomir, A., Côté, R., White, M., Lalonde, L., Blais, L., Bérard, A., & Perreault, S. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00583.x · Cited by 62
Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease
Virani, S. S., Woodard, L., Chitwood, S. S., Landrum, C. R., Urech, T. H., Wang, D., Murawsky, J., Ballantyne, C. M., & Petersen, L. A. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.07.013 · Cited by 56
Self-citation
Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial
Charland, S. L., Agatep, B. C., Herrera, V., Schrader, B. J., Frueh, F. W., Ryvkin, M., Shabbeer, J., Devlin, J. J., Superko, H. R., & Stanek, E. J. (2013) · The Pharmacogenomics Journal · doi:10.1038/tpj.2013.27 · Cited by 47
Lipid Testing and Statin Dosing After Acute Myocardial Infarction
Wang, W. T., Hellkamp, A. S., Doll, J. A., Thomas, L. E., Návar, A. M., Fonarow, G. C., Julien, H. M., Peterson, E. D., & Wang, T. Y. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.006460 · Cited by 47
Persistence with Statins and Incident Cataract: A Population-Based Historical Cohort Study
Chodick, G., Heymann, A. D., Flash, S., Kokia, E. S., & Shalev, V. (2010) · Annals of Epidemiology · doi:10.1016/j.annepidem.2009.10.007 · Cited by 45
Being Well-Informed About Statin is Associated with Continuous Adherence and Reaching Targets
Yılmaz, M. B., Pinar, M., Naharcı, M. İ., Demirkan, B., Baysan, O., Yokuşoğlu, M., Erinç, K., Tandoğan, İ., & Işık, E. (2005) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-005-5202-5 · Cited by 44
A “Hot” Topic in Dyslipidemia Management—“How to Beat a Flush”: Optimizing Niacin Tolerability to Promote Long-term Treatment Adherence and Coronary Disease Prevention
Jacobson, T. A. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0535 · Cited by 41
Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health System
Jia, X., Al Rifai, M., Ramsey, D. J., Ahmed, S. T., Akeroyd, J. M., Nambi, V., Ballantyne, C. M., Petersen, L. A., Stone, N. J., & Virani, S. S. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.04.002 · Cited by 41
Self-citation
Perspectives on low-density-lipoprotein cholesterol goal achievement
Catapano, A. L. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990802631438 · Cited by 40
Full Prescription Coverage Versus Usual Prescription Coverage After Coronary Artery Bypass Graft Surgery
Kulik, A., Desai, N. R., Shrank, W. H., Antman, E. M., Glynn, R. J., Levin, R., Reisman, L., Brennan, T. A., & Choudhry, N. K. (2013) · Circulation · doi:10.1161/circulationaha.112.000337 · Cited by 38
The first russian expert consensus on the quantitative evaluation of the treatment adherence: pivotal issues, algorithms and recommendations
Drapkina, O. M., Livzan, M. A., Martynov, A., Moiseev, S. V., Николаев, Н. А., & Skirdenko, Y. P. (2018) · Medical news of the North Caucasus · doi:10.14300/mnnc.2018.13039 · Cited by 36
Statins in Acute Coronary Syndromes
Morrissey, R. P., Diamond, G. A., & Kaul, S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.093 · Cited by 35
Recognizing and improving patient nonadherence to statin therapy
Chaudhry, H. J., & McDermott, B. P. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-008-0004-4 · Cited by 33
Physician adherence to the dyslipidemia guidelines is as challenging an issue as patient adherence
Vashitz, G., Meyer, J., Parmet, Y., Henkin, Y., Peleg, R., & Gilutz, H. (2011) · Family Practice · doi:10.1093/fampra/cmr025 · Cited by 33
EURASIAN CLINICAL GUIDELINES ON DIAGNOSIS AND TREATMENT OF ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION (STEMI)
Староверов, И. И., Shakhnovich, R. M., Gilyarov, M. Y., Komarov, A. L., Константинова, Е. В., Панченко, Е. П., & Yavelov, I. S. (2020) · Eurasian heart journal · doi:10.38109/2225-1685-2020-1-4-77 · Cited by 33
Persistence with statin therapy in Hungary
Kiss, Z., Nagy, L., Reiber, I., Paragh, G., Molnár, M. P., Rokszin, G., Abonyi‐Tóth, Z., & Márk, L. (2013) · Archives of Medical Science · doi:10.5114/aoms.2013.35327 · Cited by 27
Association between interpersonal continuity of care and medication adherence in type 2 diabetes: an observational cohort study
Dossa, R., Moisan, J., Guénette, L., Lauzier, S., & Grégoire, J. (2017) · CMAJ Open · doi:10.9778/cmajo.20160063 · Cited by 26
Impact of Lipid Monitoring on Treatment Intensification of Cholesterol Lowering Therapies (from the Veterans Affairs Healthcare System)
Jia, X., Ramsey, D. J., Rifai, M. A., Ahmed, S. T., Akeroyd, J. M., Dixon, D. L., Gluckman, T. J., Nambi, V., Ballantyne, C. M., Petersen, L. A., et al. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.12.030 · Cited by 26
Self-citation
Systematic review of clinical guidelines for lipid lowering in the secondary prevention of cardiovascular disease events
Brown, R., Welsh, P. I., & Logue, J. (2020) · Open Heart · doi:10.1136/openhrt-2020-001396 · Cited by 24
Comparison of Adherence Rates for Antiretroviral, Blood Pressure, or Mental Health Medications for HIV-Positive Patients at an Academic Medical Center Outpatient Pharmacy
Langness, J. A., Cook, P. F., Gill, J., Boggs, R., & Netsanet, N. (2014) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2014.20.8.809 · Cited by 23
El cumplimiento terapéutico en las dislipemias medido mediante monitores electrónicos. ¿Es eficaz un calendario recordatorio para evitar los olvidos?
Contreras, E. M., Martínez, J. J. C., Carrasco, J. M., de Pablos, J. L. M., González, R. C., Ruiz, C. L., & Vilas, J. C. P. (2007) · Atención Primaria · doi:10.1157/13113960 · Cited by 23
Emotional distress as a predictor of statin non-adherence among Swedish first-time myocardial infarction patients, 2006–2013
Lissåker, C., Wallert, J., Held, C., & Olsson, E. M. G. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.02.015 · Cited by 23
The From The Heart study: a global survey of patient understanding of cholesterol management and cardiovascular risk, and physician–patient communication
Hobbs, R. F., Erhardt, L., Rycroft, C. E., & on behalf of the From The heart study investigators (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x280491 · Cited by 22
Measurement of Low‐Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry
Lowenstern, A. M., Li, S., Návar, A. M., Roger, V. L., Robinson, J. G., Goldberg, A. C., Virani, S. S., Lee, L. V., Wilson, P. W. F., Louie, M. J., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009251 · Cited by 21
Lipid-Modifying Therapy and Attainment of Cholesterol Goals in Hungary
Paragh, G., M??rk, L., Z??molyi, K., Pados, G., & Ofner, P. (2007) · Clinical Drug Investigation · doi:10.2165/00044011-200727090-00006 · Cited by 21
The influence of physicians' guideline compliance on patients' statin adherence: A retrospective cohort study
Campione, J. R., Sleath, B. L., Biddle, A. K., & Weinberger, M. (2005) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2005.12.001 · Cited by 20
Quality of cholesterol screening and management with respect to the National Cholesterol Education's Third Adult Treatment Panel (ATPIII) guideline in primary care practices in North Carolina
Bertoni, A. G., Bonds, D. E., Steffes, S., Jackson, E., Crago, L., Balasubramanyam, A., Chen, H., & Goff, D. C. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.04.017 · Cited by 20
Current status of statin therapy for stroke prevention
Sett, A. K., Robinson, T. G., & Mistri, A. K. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.106 · Cited by 19
Medication Nonadherence: The Role of Cost, Community, and Individual Factors
Abbass, I. M., Revere, L., Mitchell, J. P., & Appari, A. (2016) · Health Services Research · doi:10.1111/1475-6773.12547 · Cited by 20
Lipid Management and Cholesterol Goal Attainment in Norway
Ose, L., Skjeldestad, F. E., Bakken, I. J., Levorsen, A. E., Alemao, E., Yin, D., m, F. B., & Jönsson, L. (2006) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200606020-00006 · Cited by 18
Therapy modifications and low-density lipoprotein cholesterol goal attainment rates associated with the initiation of generic simvastatin
Willey, V. J., Bullano, M. F., Shoetan, N., & Gandhi, S. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903426811 · Cited by 17
Self-citation
International patterns in lipid management and implications for patients with coronary heart disease: results from the INTERASPIRE study
Brandts, J., Barkas, F., Bacquer, D. D., Jennings, C. S., Backer, G. D., Kotseva, K., Rydén, L., Lip, G. Y. H., Erlund, I., Ganly, S., et al. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf388 · Cited by 16
Impact of a compliance program on cholesterol control: results of the randomized ORBITAL study in 8108 patients treated with rosuvastatin
Willich, S. N., Englert, H. S., Sonntag, F., Völler, H., Meyer-Sabellek, W. A., Wegscheider, K., Windier, E. T. E., Katus, H. A., & Müller‐Nordhorn, J. (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3283262ac3 · Cited by 14
Medication Adherence/Persistence and Demographics of Japanese Dyslipidemia Patients on Statin-Ezetimibe as a Separate Pill Combination Lipid-Lowering Therapy ― An Observational Pharmacy Claims Database Study ―
Umeda, T., Hayashi, A., Fujimoto, G., Piao, Y., Matsui, N., & Tokita, S. (2019) · Circulation Journal · doi:10.1253/circj.cj-18-1344 · Cited by 14
Cholesterol Level Goal Attainment with Statins: Clinical Management Guideline Recommendations versus Management in Actual Clinical Practice
Heintjes, E. M., Beest, F. J. A. P., Plat, A. W., Meerding, W. J., Webb, K., Sturkenboom, M., & Herings, R. M. C. (2012) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.2011.01086.x · Cited by 16
The importance of cholesterol follow-up testing under current statin treatment guidelines
Dansinger, M. L., Williams, P. T., Superko, H. R., & Schaefer, E. J. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.02.003 · Cited by 13
The distribution and frequency of blood lipid testing by sociodemographic status among adults in Auckland, New Zealand
Exeter, D. J., Moss, L. E., Zhao, J., Kyle, C., Riddell, T., Jackson, R., & Wells, S. J. (2015) · Journal of Primary Health Care · doi:10.1071/hc15182 · Cited by 13
Statin Intolerance and Noncompliance: An Empiric Approach
Grundy, S. M., & Vega, G. L. (2021) · The American Journal of Medicine · doi:10.1016/j.amjmed.2021.09.014 · Cited by 12
Combination Treatment with Atorvastatin plus Niacin Provides Effective Control of Complex Dyslipidemias: A Literature Review
McKenney, J. M. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.01.2513 · Cited by 11
A simple informative intervention in primary care increases statin adherence
Casula, M., Tragni, E., Piccinelli, R., Zambon, A., Fendi, L. D., Scotti, L., Corrao, G., Gambera, M., Catapano, A. L., & Filippi, A. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1975-z · Cited by 11
Validating registry data on statins prescriptions by blood measurements
Riis, A. H., Erichsen, R., Ostenfeld, E. B., Højskov, C. S., Thorlacius‐Ussing, O., Stender, M. T., Lash, T. L., & Møller, H. J. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4700 · Cited by 11
Is it cost-effective to use a test to decide which individuals with an intermediate cardiovascular disease risk would benefit from statin treatment?
Burgers, L. T., Nauta, S. T., Deckers, J. W., Severens, J. L., & Redekop, K. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.08.134 · Cited by 10
Association between continuity of primary care and both prescribing and adherence of common cardiovascular medications: a cohort study among patients in England
Tammes, P., Payne, R., & Salisbury, C. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-063282 · Cited by 10
Clinical Characteristics of Patients With Statin Discontinuation in Korea: A Nationwide Population-Based Study
Kim, K., Hong, S., Han, K., & Park, C. (2024) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2024.13.1.41 · Cited by 11
A Competing Risks Prescription Refill Model of Compliance and Persistence
Barron, T. I., Bennett, K., & Feely, J. (2010) · Value in Health · doi:10.1111/j.1524-4733.2010.00741.x · Cited by 10
Achieving Vascular Risk Factor Targets: A Survey of a London General Practice
Levine, A. P., Mikhailidis, D. P., Moross, T., Benson, K. A., & Gor, M. (2008) · Angiology · doi:10.1177/0003319707309538 · Cited by 10
Laboratory testing and antihypertensive medication adherence following initial treatment of incident, uncomplicated hypertension: A real‐world data analysis
Beall, R. F., Leung, A., Quinn, A. E., Salmon, C., Scory, T., Bresee, L. C., & Ronksley, P. (2022) · The Journal of Clinical Hypertension · doi:10.1111/jch.14567 · Cited by 6
Closing the Gaps in Care of Dyslipidemia: Revolutionizing Management with Digital Health and Innovative Care Models
Apple, S. J., Clark, R. E., Daich, J., González, M. L., Ostfeld, R. J., Toth, P. P., Bittner, V., Martin, S. S., Rana, J. S., Nasir, K., et al. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2412350 · Cited by 10
The Burden and Management of Dyslipidemia: Practical Issues
Schultz, A. B., Chen, C., Burton, W. N., & Edington, D. W. (2012) · Population Health Management · doi:10.1089/pop.2011.0081 · Cited by 9
Determinants of cholesterol goal attainment at 12 months in patients with hypercholesterolaemia not at consensus goal after 3 months of treatment with lipid-lowering drugs
Lindgren, P., Borgström, F., Stålhammar, J., Alemao, E., & Jönsson, L. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01468.x · Cited by 8
Evaluating the clinical effectiveness of the NHS Health Check programme: a prospective analysis in the Genetics and Vascular Health Check (GENVASC) study
Dębiec, R., Lawday, D., Bountziouka, V. P., Beeston, E., Greengrass, C., Bramley, R., Sehmi, S., Kharodia, S., Newton, M., Marshall, A., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068025 · Cited by 7
Lipid Management Guidelines from the Departments of Veteran Affairs and Defense: A Critique
Bennet, C. S., Dahagam, C., Virani, S. S., Martin, S. S., Blumenthal, R. S., Michos, E. D., & McEvoy, J. W. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.04.012 · Cited by 7
Impact of new Joint British Societies’ (JBS 2) guidelines on prevention of cardiovascular disease: evaluation of serum total cholesterol goal achievement in UK clinical practice
Rajagopalan, S., Alemao, E., Finch, L., & Yin, D. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x219472 · Cited by 7
The Benefits and Risks of Adherence to Medical Therapy
Scialli, A., Saavedra, K., & Fugh-Berman, A. (2021) · The Journal of Scientific Practice and Integrity · doi:10.35122/001c.21386 · Cited by 4
Screening and treatment of familial hypercholesterolemia in a French sample of ambulatory care patients: A retrospective longitudinal cohort study
Ferrières, J., Banks, V., Pillas, D., Giorgianni, F., Gantzer, L., Lekens, B., Ricci, L., Dova-Boivin, M., Chauny, J.-V., Villa, G., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255345 · Cited by 6
In-hospital statin underutilization among high-risk patients: delayed uptake of the 2013 cholesterol guidelines in a U.S. cohort
Wadia, S. K., Belkin, M. N., Chow, K. S., Nattiv, J., Appis, A., Feinstein, S. B., & Williams, K. A., Sr. (2017) · Hospital Practice · doi:10.1080/21548331.2017.1282798 · Cited by 4
Pharmacoeconomic Impact Evaluation of Statin Adherence in High-risk Unselected Post Myocardial Infarction Population: an Administrative Database-guided Analysis
Summaria, F., Ciaralli, F., Mustilli, M., Sette, A., Lanzillo, C., & Vasselli, L. (2013) · Medical Archives · doi:10.5455/medarh.2013.67.314-317 · Cited by 3
Frequency of low-density-lipoprotein-cholesterol measurement and risk of major adverse cardiovascular outcomes: a 5-million-person nationwide cohort study
Ngina, D. M., Doehner, W., Ntaios, G., Nartey, Y., & Akyea, R. K. (2025) · Global Cardiology · doi:10.4081/cardio.2025.85 · Cited by 2
Niacin—A Critical Component to the Management of Atherosclerosis: Contemporary Management of Dyslipidemia to Prevent, Reduce, or Reverse Atherosclerotic Cardiovascular Disease
Mason, C., & Doneen, A. (2012) · Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e31821bf93f · Cited by 5
Adherence, Persistence, and Predictors Associated with Early Niacin Termination
Christian, J. B., Rabatin, V., & Lowe, K. A. (2013) · Journal of Pharmacy Technology · doi:10.1177/875512251302900406 · Cited by 2
Effect of Lipid-Testing Interval on Stoke Risk among Newly Diagnosed Dyslipidemia Patients Initiated on Statins
Ko, A., Choi, S., Chang, J., & Park, S. M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050742 · Cited by 2
Lipid Monitoring After Initiation of Lipid-Lowering Therapies: Return of Performance Measures?
Deshotels, M. R., Virani, S. S., & Ballantyne, C. M. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01545-9 · Cited by 2
Self-citation
Mortality and Adherence to Pharmacotherapy After Acute Myocardial Infarction
Kinjo, M., Kinjo, K., Iwata, I., & Setoguchi, S. (2007) · JAMA · doi:10.1001/jama.297.17.1877-b · Cited by 2
Group-Based Trajectory Models to Evaluate the Association of Lipid Testing and Statin Adherence
Pan, Y.-Y., Devabhakthuni, S., Cooke, C. E., & Slejko, J. F. (2024) · Drugs - Real World Outcomes · doi:10.1007/s40801-024-00472-9 · Cited by 1

Authors: Benner, J. S., Tierce, J. C., Ballantyne, C. M., Prasad, C., Bullano, M. F., Willey, V. J., Erbey, J., & Sugano, D. S.
Affiliations: Baylor College of Medicine (US)
Corresponding author: Benner, Joshua S.
ORCID: Ballantyne, Christie M.
Bullano, Michael F.
Willey, Vincent J.
Venue: PharmacoEconomics
Publisher: Springer Science and Business Media LLC
Published: 2004-11
Volume: 22
Issue: S3
Pages: 13-23
ISSN: 1170-7690 (ISSN-L)
1179-2027
DOI: 10.2165/00019053-200422003-00003
OpenAlex: W2058622522
Cited by: 115
References: 37
Citations by year: 2026: 1 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 7 · 2020: 7 · 2019: 10 · 2018: 8 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 3 · 2013: 8 · 2012: 5
FWCI: 6.14
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (unspecified)
Locations: PharmacoEconomics (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
Keywords: statin therapy, medication adherence, lipid testing, dyslipidemia, lipid-lowering therapy, managed care, National Cholesterol Education Program, secondary prevention
MeSH terms: Adolescent, Adult, Aged, Coronary Disease, Female, Humans, Hyperlipidemias, Lipids, Male, Middle Aged, Patient Compliance, Physician-Patient Relations, Practice Patterns, Physicians', Retrospective Studies, Risk Factors, Time Factors, United States, Cohort Studies, Multivariate Analysis, Hydroxymethylglutaryl-CoA Reductase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks